EUVIMEDEUVIMED entdecken
Multizentrische Studie

Real-World Outcomes of Pyrotinib-Based Therapy for HER2-Positive Breast Cancer With Brain Metastases: A Multicentre, Retrospective Analysis

Muxin Wu, Sen Lei, Yijing Tang, Chengzu He, Jian Zhang, Xin'an Lu, Aihua Tan, Hongxue Wang, Weimin Xie

Clinical Breast Cancer · 2025

DOI: 10.1016/j.clbc.2024.11.005 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Muxin Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast, Bone&Soft Tissue Oncology, Guangxi Medical University Cancer Hospital, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Acrylamides, Brain Neoplasms, Aminoquinolines. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAcrylamidesBrain NeoplasmsAminoquinolinesAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMiddle AgedErb-b2 Receptor Tyrosine KinasesRetrospective StudiesAdultAgedFollow-Up StudiesSurvival RateProgression-Free SurvivalTreatment Outcome

Stichwörter der Autor:innen

Human epidermal growth factor receptor 2 (HER2)Metastatic breast cancerReal-world studyTargeted therapy

Substanzen

AcrylamidesErb-b2 Receptor Tyrosine KinasesAminoquinolinespyrotinibERBB2 protein, human

Autor:innen und Institutionen

  • Department of Breast, Bone&Soft Tissue Oncology, Guangxi Medical University Cancer Hospital, China.
  • Department of Oncology, Binyang People's Hospital, China.
  • Department of Oncology, Laibin People's Hospital, China.
  • Department of Oncology, Hengzhou People's Hospital, China.
  • Department of Breast, Bone&Soft Tissue Oncology, Guangxi Medical University Cancer Hospital, China. Electronic address: xieweimin060@163.com.

Zitieren

APA

Wu, M., Lei, S., Tang, Y., He, C., Zhang, J., Lu, X., Tan, A., Wang, H., & Xie, W. (2025). Real-World Outcomes of Pyrotinib-Based Therapy for HER2-Positive Breast Cancer With Brain Metastases: A Multicentre, Retrospective Analysis. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2024.11.005

Vancouver

Wu M, Lei S, Tang Y, He C, Zhang J, Lu X, et al. Real-World Outcomes of Pyrotinib-Based Therapy for HER2-Positive Breast Cancer With Brain Metastases: A Multicentre, Retrospective Analysis. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2024.11.005

BibTeX
@article{Wu2025,
  author = {Wu, Muxin and Lei, Sen and Tang, Yijing and He, Chengzu and Zhang, Jian and Lu, Xin'an and Tan, Aihua and Wang, Hongxue and Xie, Weimin},
  title = {Real-World Outcomes of Pyrotinib-Based Therapy for HER2-Positive Breast Cancer With Brain Metastases: A Multicentre, Retrospective Analysis},
  journal = {Clinical Breast Cancer},
  year = {2025},
  doi = {10.1016/j.clbc.2024.11.005}
}
Kostenlos starten →